Why does insulin promote glycolysis

By contrast, heterodimeric nuclear receptors reside in the nucleus and are bound to their cognate binding sites together with the universal binding partner retinoid X receptor RXR. Examples of this class of nuclear receptors include members of peroxisome proliferator-activated receptors, LXRs, vitamin D receptors and thyroid hormone receptors.

The final subclasses of nuclear receptors are types that function as monomers. They usually lack specific endogenous ligands and are often called orphan nuclear receptors.

Some of them also lack DNA binding domain and thus function as transcriptional repressors of various transcription factors, including members of nuclear receptors. They are called atypical orphan nuclear receptors. Among the homodimeric nuclear receptors, the role of GR has been linked to the control of hepatic gluconeogenesis. GR is activated by cortisol, which is released from the adrenal cortex in response to chronic stresses such as prolonged fasting.

The same response elements were also shown to be recognized and regulated by hepatocyte nuclear factor 4 HNF4 , a member of heterodimeric nuclear receptors, which suggests that these nuclear receptors could coordinately function to control hepatic gluconeogenesis in response to fasting.

This factor regulates hepatic gluconeogenesis by binding to unique response elements that are distinct from the known nuclear receptor-binding sites in the promoters of PEPCK and G6Pase. These results provide a dual mechanism for a metformin-AMPK dependent pathway to inhibit hepatic gluconeogenesis at the transcriptional level; an acute regulation of CRTC2 phosphorylation to inhibit the CRTC2-CREB-dependent transcriptional circuit; and a longer-term regulation of gluconeogenic transcription by enhanced SHP expression.

Further study is necessary to fully understand the relative contribution of these nuclear receptors in the control of glucose homeostasis in both physiological conditions and pathological settings. In this review, we attempted to describe the current understanding of the regulation of glucose metabolism in the mammalian liver. Under feeding conditions, glucose, a major hexose monomer of dietary carbohydrate, is taken up in the liver and oxidized via glycolysis.

The excess glucose that is not utilized as an immediate fuel for energy is stored initially as glycogen and is later converted into triacylglycerols via lipogenesis. Glycogenesis is activated via the insulin-Akt-mediated inactivation of GSK-3, leading to the activation of glycogen synthase and the increased glycogen stores in the liver.

Insulin is also critical in the activation of PP1, which functions to dephosphorylate and activate glycogen synthase.

Two prominent transcription factors are SREBP-1c and ChREBP, which regulate not only the aforementioned glycolytic enzyme genes but also the genes encoding enzymes for fatty acid biosynthesis and triacylglycerol synthesis collectively termed as lipogenesis.

The importance of these transcription factors in the control of glycolysis and fatty acid biosynthesis has been verified by knockout mouse studies, as described in the main text. The liver also has a critical role in controlling glucose homeostasis under fasting conditions.

Initially, insulin counterregulatory hormones such as glucagon and epinephrine are critical in activating the PKA-driven kinase cascades that promote glycogen phosphorylase and glycogenolysis in the liver, thus enabling this tissue to provide enough fuel for peripheral tissues such as the brain, red blood cells and muscles. These adaptive responses are critical for maintaining glucose homeostasis in times of starvation in mammals.

Further study is necessary by using liver-specific knockout mice for each regulator of hepatic glucose metabolism to provide better insights into the intricate control mechanisms of glucose homeostasis in mammals. Regulation of glucose production by the liver. Annul Rev Nutr ; 19 : — Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu Rev Nutr ; 17 : — Roach PJ. Glycogen and its metabolism. Curr Mol Med ; 2 : — Liver glycogen metabolism: an overview. Diabetes Metab Rev ; 3 : 47— Control of liver glycogen synthase activity and intracellular distribution by phosphorylation.

The J Biol Chem ; : — Agius L. Role of glycogen phosphorylase in liver glycogen metabolism. Mol Aspects Med ; 46 : 34— Annu Rev Nutr ; 11 : — The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis.

Adv Second Messenger Phosphoprotein Res ; 22 : — Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem ; 57 : — Modulation of glucokinase regulatory protein: a double-edged sword?

Trends Mol Med ; 21 : — Carbohydrate responsive element binding protein ChREBP and sterol regulatory element binding protein-1c SREBP-1c : two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie ; 87 : 81— SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest ; : — Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes.

J Biol Chem ; : — Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab ; 13 : — SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab ; 23 : 65— Genes Dev ; 14 : — Lu M, Shyy JY. Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver.

Mlx in regulating hepatic glucose-responsive genes. The nuclear receptor LXR is a glucose sensor. Nature ; : — Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase.

Biochem J ; : — Biochem Biophys Res Commun ; : — Iizuka K, Horikawa Y. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J ; 55 : — Diabetes ; 55 : — BMB Rep ; 46 : — Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.

Altarejos JY, Montminy M. Nat Rev Mol Cell Biol ; 12 : — Mol Cell ; 12 2 : — Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein.

Cell Metab ; 10 : — Disrupting the CH1 domain structure in the acetyltransferases CBP and p results in lean mice with increased metabolic control. Cell Metab ; 14 : — Cell ; : 61— Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. Science ; : — Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism. Sci Signal ; 7 : ra PubMed Article Google Scholar.

Cell Metab ; 11 : — Accili D, Arden KC. Glucose Tolerance Test : evaluates how quickly an individual can restore their blood glucose to normal following ingestion of a large amount of glucose, i. Diabetic : can not produce or respond to insulin so thus has a very low glucose tolerance. Obese Individuals : even with prolonged medically supervised fasting have plasma glucose levels that remain relatively constant even after three months.

Fatty acids are mobilized from adipose and their rate of oxidation by muscle is increased, which in turn decreases glucose utilization. Fatty acid release by adipose is reduced by insulin, thus decreasing fatty acid oxidation. The regulatory effect of fatty acid oxidation on glucose utilization is logical :.

In muscle : fatty acid oxidation decreases glucose utilization through negative effects on glucose transport as well as on the activities of hexokinase, PFK-1 and pyruvate DH.

Elevated levels of plasma fatty acids increase muscle oxidation of this fuel. Ketones : produced from excess fatty acids, provide an alternate fuel and limit glucose oxidation in a similar way as fats, even in the brain. The effects of insulin on glucose metabolism vary depending on the target tissue. Two important effects are:. Insulin facilitates entry of glucose into muscle, adipose and several other tissues.

The only mechanism by which cells can take up glucose is by facilitated diffusion through a family of hexose transporters. In many tissues - muscle being a prime example - the major transporter used for uptake of glucose called GLUT4 is made available in the plasma membrane through the action of insulin.

When insulin concentrations are low, GLUT4 glucose transporters are present in cytoplasmic vesicles, where they are useless for transporting glucose. Binding of insulin to receptors on such cells leads rapidly to fusion of those vesicles with the plasma membrane and insertion of the glucose transporters, thereby giving the cell an ability to efficiently take up glucose.

When blood levels of insulin decrease and insulin receptors are no longer occupied, the glucose transporters are recycled back into the cytoplasm. It should be noted here that there are some tissues that do not require insulin for efficient uptake of glucose: important examples are brain and the liver.

This is because these cells don't use GLUT4 for importing glucose, but rather, another transporter that is not insulin-dependent. Insulin stimulates the liver to store glucose in the form of glycogen. A large fraction of glucose absorbed from the small intestine is immediately taken up by hepatocytes, which convert it into the storage polymer glycogen. Insulin has several effects in liver which stimulate glycogen synthesis.

First, it activates the enzyme hexokinase, which phosphorylates glucose, trapping it within the cell. Coincidently, insulin acts to inhibit the activity of glucosephosphatase. Insulin also activates several of the enzymes that are directly involved in glycogen synthesis, including phosphofructokinase and glycogen synthase. The net effect is clear: when the supply of glucose is abundant, insulin "tells" the liver to bank as much of it as possible for use later.

A well-known effect of insulin is to decrease the concentration of glucose in blood , which should make sense considering the mechanisms described above. Another important consideration is that, as blood glucose concentrations fall, insulin secretion ceases.

In the absense of insulin, a bulk of the cells in the body become unable to take up glucose, and begin a switch to using alternative fuels like fatty acids for energy. Neurons, however, require a constant supply of glucose, which in the short term, is provided from glycogen reserves.

When insulin levels in blood fall, glycogen synthesis in the liver diminishes and enzymes responsible for breakdown of glycogen become active. Glycogen breakdown is stimulated not only by the absense of insulin but by the presence of glucagon , which is secreted when blood glucose levels fall below the normal range.

The metabolic pathways for utilization of fats and carbohydrates are deeply and intricately intertwined. Considering insulin's profound effects on carbohydrate metabolism, it stands to reason that insulin also has important effects on lipid metabolism, including the following:. Insulin promotes synthesis of fatty acids in the liver.